Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10845424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

  2000cited by this paper
• Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2

  1999cited by this paper
• Inhibition of RNA polymerase II as a trigger for the p53 response

  1999cited by this paper
• Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.

  1999cited by this paper
• Eponemycin exerts its antitumor effect through the inhibition of proteasome function.

  1999cited by this paper
• How the cyclin became a cyclin: Regulated proteolysis in the cell cycle

  1999cited by this paper
• Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.

  1999cited by this paper
• An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.

  1999cited by this paper
• DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization

  1999cited by this paper
• Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest.

  1999cited by this paper
• A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

  1999cited by this paper
• Proteasome inhibitors: a novel class of potent and effective antitumor agents.

  1999cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts

  1998influential reference
• Cooperation of a Single Lysine Mutation and a C-terminal Domain in the Cytoplasmic Sequestration of the p53 Protein*

  1998cited by this paper
• Butyrate attenuates BCLX(L) expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis.

  1998cited by this paper
• Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53

  1998influential reference
• Phosphorylation of p53 Serine 15 Increases Interaction with CBP*

  1998cited by this paper
• DNA damage activates p53 through a phosphorylation-acetylation cascade.

  1998cited by this paper
• mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.

  1998cited by this paper
• JNK targets p53 ubiquitination and degradation in nonstressed cells.

  1998cited by this paper
• A p53-independent pathway for induction of p21waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts.

  1997cited by this paper
• Mechanism of p53 degradation.

  1997cited by this paper
• Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.

  1997influential reference
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Activation of the cell death program by inhibition of proteasome function.

  1997cited by this paper
• Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• p53-dependent Induction of Apoptosis by Proteasome Inhibitors*

  1997cited by this paper
• DNA damage induces phosphorylation of the amino terminus of p53.

  1997cited by this paper
• Transcriptional squelching by ectopic expression of E2F-1 and p53 is alleviated by proteasome inhibitors MG-132 and lactacystin

  1997cited by this paper
• Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• The ubiquitin system.

  1997cited by this paper
• p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts.

  1996cited by this paper
• Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis.

  1996cited by this paper
• Proteasomes: destruction as a programme.

  1996cited by this paper
• In vivo ubiquitination and proteasome-mediated degradation of p53(1).

  1996influential reference
• Proteasomes play an essential role in thymocyte apoptosis.

  1996cited by this paper
• The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.

  1996cited by this paper
• Apoptosis induction resulting from proteasome inhibition.

  1996cited by this paper
• Involvement of the proteasome in the programmed cell death of NGF‐deprived sympathetic neurons.

  1996cited by this paper
• Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.

  1995cited by this paper
• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995cited by this paper
• p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.

  1995cited by this paper
• Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

  1994cited by this paper
• Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

  1994cited by this paper
• Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway

  1994cited by this paper
• Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram.

  1989cited by this paper
• UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells

  1984cited by this paper

• Therapeutic Effects of Crocin Nanoparticles Alone or in Combination with Doxorubicin against Hepatocellular Carcinoma In vitro.

  2024cites this paper
• The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells.

  2023cites this paper
• Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment

  2022cites this paper
• Carfilzomib Induces Drug Resistance in A2780 Ovarian Cancer Cells Through p53-Dependent and Caspase-3 Independent Pathways

  2019cites this paper
• Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of both Normal and Tumor Tissues In Vivo.

  2019cites this paper
• A proteomic analysis of the statocyst endolymph in common cuttlefish (Sepia officinalis): an assessment of acoustic trauma after exposure to sound

  2019cites this paper
• Miniature Non-thermal Plasma Induced Cell Cycle Arrest and Apoptosis in Lung Carcinoma Cells

  2019cites this paper
• Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells

  2017cites this paper
• Investigation of non-thermal plasma effects on lung cancer cells within 3D collagen matrices

  2017cites this paper
• Non-thermal plasma treatment altered gene expression profiling in non-small-cell lung cancer A549 cells

  2015cites this paper
• Non-thermal plasma treatment altered gene expression profiling in non-small-cell lung cancer

  2015cites this paper
• Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

  2014cites this paper
• Semi-purified extracts of Commelina benghalensis (Commelinaceae) induce apoptosis and cell cycle arrest in Jurkat-T cells

  2014cites this paper
• Proteomic evaluation of potentiated sulfa treatment on gilthead sea bream (Sparus aurata L.) liver

  2013cites this paper
• Inhibition of ubiquitin-proteasome pathway: A possible treatment of hepatocellular carcinoma

  2013cites this paper
• Proteasome Inhibition as a Novel Strategy for Cancer Treatment

  2013cites this paper
• Activation of p53 Signaling and Inhibition of Androgen Receptor Mediate Tanshinone IIA Induced G1 Arrest in LNCaP Prostate Cancer Cells

  2012cites this paper
• Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association.

  2012cites this paper
• Developing biomarkers for mussel leukemia as tools for ecosystem health monitoring

  2012cites this paper
• Editorial Biochemical Pathways in Cancer

  2012cites this paper
• Detrimental effects of proteasome inhibition activity in Drosophila melanogaster: implication of ER stress, autophagy, and apoptosis

  2012cites this paper
• Biochemical Pathways in Cancer

  2012cites this paper
• Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.

  2011cites this paper
• Global and specific controls of protein synthesis in hibernators

  2011cites this paper
• Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells.

  2011cites this paper
• Role for p53 in selenium-induced senescence.

  2011cites this paper
• Metals Induced Disruption of Ubiquitin Proteasome System, Activation of Stress Signaling and Apoptosis

  2011cites this paper
• Calcium fructoborate: plant-based dietary boron as potential medicine for cancer therapy.

  2011cites this paper
• Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

  2011cites this paper
• Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.

  2010cites this paper
• Cancer esearch apeutics , Targets , and Chemical Biology geting Wild-Type and Mutant p 53 with Small Molecule 31398 Blocks the Growth of Rhabdomyosarcoma by R cing Reactive Oxygen Species – Dependent Apoptosis

  2010cites this paper
• Gilthead sea bream liver proteome altered at low temperatures by oxidative stress

  2010cites this paper
• The effect of ethanolic and petroleum ether fractions of bawang dayak (Eleutherine palmifolia) bulb extract on expression of p53 mutant in breast cancer cell line T47D

  2010cites this paper
• Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib

  2010cites this paper
• Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation

  2009cites this paper
• Pro-apoptotic effects of parathyroid hormone in intestinal cells.

  2009cites this paper
• The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.

  2009cites this paper
• Targeting the DNA damage response in cancer.

  2009cites this paper
• Proteasome inhibition suppresses essential immune functions of human CD4+ T cells

  2008cites this paper
• Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells

  2008cites this paper
• Anti-tumor action and clinical application of proteasome inhibitor

  2008cites this paper
• Comparative Effects of Boric Acid and Calcium Fructoborate on Breast Cancer Cells

  2008cites this paper
• Cadmium-induced activation of stress signaling pathways, disruption of ubiquitin-dependent protein degradation and apoptosis in primary rat Sertoli cell-gonocyte cocultures.

  2008cites this paper
• The ubiquitin-proteasome system in colorectal cancer.

  2008cites this paper
• DNA damage in post-mitotic neurons is proposed to contribute to neuronal loss and/or functional deficits in several neurological disorders including Alzheimer’s disease, stroke and neurotoxicity of anticancer chemotherapy (Nou-

  2008cites this paper
• Inhibition of nucleolar transcription as a trigger for neuronal apoptosis

  2008cites this paper
• Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.

  2008cites this paper
• Metabolic control of proteasome function.

  2007cites this paper
• Reprogramming of nuclear proteasomes under apoptosis induction in K562 cells II. Effect of antitumor drug doxorubicin

  2007cites this paper
• Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats.

  2007cites this paper
• Ubiquitin-Proteasome System and Its Regulation

  2007cites this paper
• Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox-2

  2007cites this paper
• The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

  2007cites this paper
• Caspase‐8 dependent osteosarcoma cell apoptosis induced by proteasome inhibitor MG132

  2007cites this paper
• Characterization of the pro-apoptotic function of eIF5A in human cancer cell lines

  2007cites this paper
• p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.

  2007cites this paper
• The proteasome inhibitor lactacystin attenuates growth and migration of vascular smooth muscle cells and limits the response to arterial injury.

  2007cites this paper
• Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells

  2006cites this paper
• Quantifizierung von infektiösen rAAV-2-Partikeln und deren therapeutischer Einsatz bei nicht-kleinzelligen Bronchialkarzinom- Zelllinien

  2006cites this paper
• Post‐translational modification by O‐GlcNAc: Another way to change protein function

  2006cites this paper
• Prevention of p53 Degradation in Human MCF‐7 Cells by Proteasome Inhibitors Does Not Mimic the Action of Roscovitine

  2006cites this paper
• Nutritional regulation of proteases involved in fetal rat insulin secretion and islet cell proliferation

  2005cites this paper
• The natural toxin juglone causes degradation of p53 and induces rapid H2AX phosphorylation and cell death in human fibroblasts.

  2005cites this paper
• The Proteasome as a Target for Cancer Treatment

  2005cites this paper
• The Proteasome in Cell-Cycle Regulation

  2004cites this paper
• Proteasome Inhibition and Apoptosis

  2004cites this paper
• Investigation of the ubiquitin-specific protease UBP41 and of the lysosomal cysteine proteases cathepsin-L and cathepsin-B as potential mediators of proapoptotic signalling

  2004cites this paper
• Phosphorylation and nuclear accumulation are distinct events contributing to the activation of p53.

  2004cites this paper
• Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo.

  2004cites this paper
• Multiple Forms of Proteasomes and Approaches to Their Separation

  2004cites this paper
• Apoptosis in Parkinson's disease: Signals for neuronal degradation

  2003cites this paper
• Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates.

  2003cites this paper
• Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1*

  2003cites this paper
• Extracellular matrix-regulated p53 expression and nuclear localization in cultured Detroit 562 cells derived from pharyngeal carcinoma.

  2003cites this paper
• p53-induced inhibition of protein synthesis is independent of apoptosis.

  2003cites this paper
• Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons.

  2003cites this paper
• Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation

  2003influential citation
• Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer.

  2003cites this paper
• Deletion of the SNARE vti1b in Mice Results in the Loss of a Single SNARE Partner, Syntaxin 8

  2003cites this paper
• Lactacystin augments the sulindac-induced apoptosis in HT-29 cells

  2003cites this paper
• The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells.

  2003cites this paper
• O-GlcNAc modification is an endogenous inhibitor of the proteasome.

  2003cites this paper
• Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.

  2003cites this paper
• Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest.

  2002influential citation
• Phenylbutyrate inhibits the invasive properties of prostate and breast cancer cell lines in the sea urchin embryo basement membrane invasion assay

  2002cites this paper
• Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.

  2002cites this paper
• Diet activity, and lifestyle associations with p53 mutations in colon tumors.

  2002cites this paper
• Proteasome inhibition: a novel approach to cancer therapy.

  2002cites this paper
• The Proteasome: Destroy to Live

  2002cites this paper
• Modulating cell cycle: current applications and prospects for future drug development.

  2002cites this paper
• Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma*

  2001cites this paper
• The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382.

  2001cites this paper
• Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress.

  2001cites this paper
• Modulation of cell cycle‐related protein expression by sodium butyrate in human non‐small cell lung cancer cell lines

  2001cites this paper
• Ubiquitin proteasome pathway: implications and advances in cancer therapy.

  2001cites this paper
• Ligand-dependent Degradation of Src-1 Is Pivotal for Progesterone Receptor Transcriptional Activity. Ligand-dependent Degradation of Src-1 Is Pivotal for Progesterone Receptor Transcriptional Activity

  year unknowncites this paper